Philip Ashton
Dr Philip Ashton's mission is to apply genomics to improve public health in high infectious disease burden countries.
He has experience of delivering innovative public health services during four years with Public Health England, when he was part of the team who introduced whole genome sequencing into frontline practice for Salmonella infections.
Between 2016 and 2025 he lived and worked in Vietnam and Malawi on Mycobacterium tuberculosis, Cryptococcus neoformans, and invasive Salmonella infections.
Since 2025 he has worked at the Centre for Genomic Pathogen Surveillance, as the lead genomic epidemiologist, with a focus on using microbial genomics to improve public health interventions against AMR.
He is particularly interested in Salmonella infections and the role of the microbiota in susceptibility to infection.
A list of his publication is available on Google Scholar - https://scholar.google.com/citations?user=JPi-2JAAAAAJ&hl=en&authuser=1
Recent publications
-
A description of lineage 1 Mycobacterium tuberculosis from papua, Indonesia.
Journal article
Djunaedy HAK. et al, (2024), Tuberculosis (Edinburgh, Scotland), 149
-
Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study.
Journal article
Dyson ZA. et al, (2024), The Lancet. Microbe, 5
-
Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study.
Journal article
Ashton PM. et al, (2024), The Lancet. Microbe, 5, e226 - e234
-
Typhi Mykrobe: fast and accurate lineage identification and antimicrobial resistance genotyping directly from sequence reads for the typhoid fever agentSalmonellaTyphi
Preprint
Ingle D. et al, (2024)
-
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
Journal article
Carey ME. et al, (2023), eLife, 12